ARNA Therapeutics
Amorchem
- Headquarters
- Quebec City
- Employees
- 1–10
- Business Model
- B2B
- Website
- amorchem.com
- Last Round
- SeedJan 2018
- Rounds
- 1
About
ARNA Therapeutics is a Quebec biotechnology company applying research in neuroinflammation and central nervous system disease to RNA regulation. Its complementary development approaches target TDP-43 and SRSF3 with the goal of creating new therapeutic options for people living with amyotrophic lateral sclerosis and frontotemporal dementia spectrum disorder. The company was formed by expanding an earlier AmorChem-backed program with an asset acquired by the Canadian biotechnology company ImStar.
Summary
ARNA Therapeutics is a Healthcare company based in Quebec City, Canada. Its most recent funding was a Seed round in Jan 2018. Investors include BDC Venture Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2018
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arna-therapeutics"><img src="https://indexed.vc/api/badge/company/arna-therapeutics" alt="ARNA Therapeutics on Indexed.vc" width="260" height="76" /></a>